Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DOWSETT M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 154 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Johnston, S; Dowsett, M
      Special issue: Signal transduction inhibition - from concept to clinic - Foreword

      ENDOCRINE-RELATED CANCER
    2. Dowsett, M
      Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer

      ENDOCRINE-RELATED CANCER
    3. Geisler, J; Detre, S; Berntsen, H; Ottestad, L; Lindtjorn, B; Dowsett, M; Lonning, PE
      Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer

      CLINICAL CANCER RESEARCH
    4. Kelland, LR; Smith, V; Valenti, M; Patterson, L; Clarke, PA; Detre, S; End, D; Howes, AJ; Dowsett, M; Workman, P; Johnston, SRD
      Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer

      CLINICAL CANCER RESEARCH
    5. Dowsett, M; Bundred, NJ; Decensi, A; Sainsbury, RC; Lu, YL; Hills, MJ; Cohen, FJ; Veronesi, P; O'Brien, MER; Scott, T; Muchmore, DB
      Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    6. Harper-Wynne, C; Dowsett, M
      Recent advances in the clinical application of aromatase inhibitors

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    7. Parton, M; Dowsett, M; Smith, I
      Studies of apoptosis in breast cancer

      BRITISH MEDICAL JOURNAL
    8. Dowsett, M; Harper-Wynne, C; Boeddinghaus, I; Salter, J; Hills, M; Dixon, M; Ebbs, S; Gui, G; Sacks, N; Smith, I
      HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer

      CANCER RESEARCH
    9. Robertson, JF; Nicholson, RI; Bundred, NJ; Anderson, E; Rayter, Z; Dowsett, M; Fox, JN; Gee, JMW; Webster, A; Wakeling, AE; Morris, C; Dixon, M
      Comparison of the short-term biological effects of 7 alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17 beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer

      CANCER RESEARCH
    10. Baum, M; Dowsett, M; Coibion, M; Bianco, AR; Cuzick, J; George, WD; Gray, J; Howell, A; Houghton, J; Williams, N; Sloane, J; Tobias, J; Buzdar, A; Anderson, MD; Jackson, I; Sahmoud, T; Gallagher, J; Webster, A; Gangji, D; Petrakova, K; Konopasek, B; Mares, P; Vodvarka, P; Alcazar, A; Campos, O; Maxwell, A; Goedhals; Hacking, D; Landers, G; Smith, L; Vorobiof, DA; Werner, ID; Blamey, R; Coleman, R; Grieve, RJ; Hickish, T; Howell, A; Nicholls, JC; Nicholson, S; Raymond, S; Salman, A; Blum, J; Clark, R; Lyss, A; Miletello, G; Sternberg, J; Forbes, J; Coibion, M; Nabholtz, JM; Guastalla, JP; Distler, W; Klijn, JGM; Nagykalnai, T; Nicolucci, A; Bianco, AR; Constenla, M; Nylen, U; Howell, A; Sainsbury, R; Mansel, RE; Goerge, D; Buzdar, AU; Locker, GY; Gallagher, J; Jackson, I; Sahmoud, T; Houghton, J; Williams, N; Nicolucci, A; Pollard, S; Stroner, P; Buyse, M; Margolese, R; Northover, JMA
      Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex (TM) and Tamoxifen Alone or in Combination' (ATAC) trial

      BRITISH JOURNAL OF CANCER
    11. Dowsett, M
      Aromatase inhibition: The outcome of 20 years of drug development

      AROMATASE INHIBITION AND BREAST CANCER
    12. Johnston, SRD; Smith, IE; Dowsett, M
      Place of aromatase inhibitors in the endocrine therapy of breast cancer

      AROMATASE INHIBITION AND BREAST CANCER
    13. Dowsett, M
      New hurdles for translational research

      BREAST CANCER RESEARCH
    14. Dowsett, M; Dixon, JM; Horgan, K; Salter, J; Hills, M; Harvey, E
      Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer

      CLINICAL CANCER RESEARCH
    15. Chang, J; Powles, TJ; Allred, DC; Ashley, SE; Makris, A; Gregory, RK; Osborne, CK; Dowsett, M
      Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients

      CLINICAL CANCER RESEARCH
    16. Dowsett, M; Cooke, T; Ellis, I; Gullick, WJ; Gusterson, B; Mallon, E; Walker, R
      Assessment of HER2 status in breast cancer: why, when and how?

      EUROPEAN JOURNAL OF CANCER
    17. Dowsett, M
      Use of risk determinants for different breast cancer prevention strategies

      EUROPEAN JOURNAL OF CANCER
    18. Chang, J; Powles, TJ; Allred, DC; Ashley, SE; Clark, GM; Dowsett, M
      Predictors of response to chemotherapy - In Reply

      JOURNAL OF CLINICAL ONCOLOGY
    19. Dowsett, M; Donaldson, K; Tsuboi, M; Wong, J; Yates, R
      Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    20. Zabaglo, L; Ormerod, MG; Dowsett, M
      Measurement of markers for breast cancer in a model system using laser scanning cytometry

      CYTOMETRY
    21. Gregory, RK; Powles, TJ; Salter, J; Chang, JC; Ashley, S; Dowsett, M
      Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

      BREAST CANCER RESEARCH AND TREATMENT
    22. Ellis, IO; Dowsett, M; Bartlett, J; Walker, R; Cooke, T; Gullick, W; Gusterson, B; Mallon, E; Lee, PB
      Recommendations for HER2 testing in the UK

      JOURNAL OF CLINICAL PATHOLOGY
    23. van der Flier, S; Chan, CMW; Brinkman, A; Smid, M; Johnston, SRD; Dorssers, LCJ; Dowsett, M
      BCAR1/p130CAS expression in untreated and acquired tamoxifen-resistant human breast carcinomas

      INTERNATIONAL JOURNAL OF CANCER
    24. Chang, J; Ormerod, M; Powles, TJ; Allred, DC; Ashley, SE; Dowsett, M
      Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma

      CANCER
    25. Leake, R; Anderson, L; Dowsett, M; Iles, R; Nicholson, R; Robertson, J; Walker, R
      Can biological markers improve the management of breast cancer patients?

      BRITISH JOURNAL OF CANCER
    26. Leake, R; Anderson, L; Dowsett, M; Iles, R; Nicholson, R; Robertson, J; Walker, R
      Biological markers: maintaining standards

      BRITISH JOURNAL OF CANCER
    27. Archer, C; Trott, P; Dowsett, M
      Apoptosis pathways - Clinical relevance

      PRINCIPLES OF MOLECULAR ONCOLOGY
    28. Dowsett, M
      Drug and hormone interactions of aromatase inhibitors

      ENDOCRINE-RELATED CANCER
    29. Coombes, RC; Harper-Wynne, C; Dowsett, M
      Aromatase inhibitors and their use in the sequential setting

      ENDOCRINE-RELATED CANCER
    30. Ingle, JN; Suman, VJ; Jordan, VC; Dowsett, M
      Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer

      ENDOCRINE-RELATED CANCER
    31. Dowsett, M
      Special section: Cell death in breast cancer

      ENDOCRINE-RELATED CANCER
    32. Dowsett, M; Archer, A; Assersohn, L; Gregory, RK; Ellis, PA; Salter, J; Chang, J; Mainwaring, P; Boeddinghaus, I; Johnston, SRD; Powles, TJ; Smith, IE
      Clinical studies of apoptosis and proliferation in breast cancer

      ENDOCRINE-RELATED CANCER
    33. Haynes, B; Dowsett, M
      Clinical pharmacology of selective estrogen receptor modulators

      DRUGS & AGING
    34. Dowsett, M; Pfister, C; Johnston, SRD; Miles, DW; Houston, SJ; Verbeek, JA; Gundacker, H; Sioufi, A; Smith, IE
      Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer

      CLINICAL CANCER RESEARCH
    35. Ingle, JN; Suman, VJ; Johnson, PA; Krook, JE; Mailliard, JA; Wheeler, RH; Loprinzi, CL; Perez, EA; Jordan, VC; Dowsett, M
      Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer

      CLINICAL CANCER RESEARCH
    36. Propper, DJ; Saunders, MP; Salisbury, AJ; Long, L; O'Byrne, KJ; Braybrooke, JP; Dowsett, M; Taylor, M; Talbot, DC; Ganesan, TS; Harris, AL
      Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: Toxicity, hormonal, and immunological effects

      CLINICAL CANCER RESEARCH
    37. Johnston, SRD; Lu, B; Scott, GK; Kushner, PJ; Smith, IE; Dowsett, M; Benz, CC
      Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance

      CLINICAL CANCER RESEARCH
    38. Chan, CMW; Lykkesfeldt, AE; Parker, MG; Dowsett, M
      Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptorinteracting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer

      CLINICAL CANCER RESEARCH
    39. Harper-Wynne, C; Hills, MJ; Nasiri, N; Salter, J; Dowsett, M
      Estimation of proliferative activity in normal postmenopausal breast tissue using core biopsy

      BREAST
    40. Bajetta, E; Zilembo, N; Dowsett, M; Guillevin, L; Di Leo, A; Celio, L; Martinetti, A; Marchiano, A; Pozzi, P; Stani, S; Bichisao, E
      Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

      EUROPEAN JOURNAL OF CANCER
    41. Vorobiof, DA; Kleeberg, UR; Perez-Carrion, R; Dodwell, DJ; Robertson, JFR; Calvo, L; Dowsett, M; Clack, G
      A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex (R)) with intramuscular formestane in postmenopausal women with advanced breast cancer

      ANNALS OF ONCOLOGY
    42. Chang, J; Powles, TJ; Allred, DC; Ashey, SE; Clark, GM; Makris, A; Assersohn, L; Gregory, RK; Osborne, CK; Dowsett, M
      Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    43. Dowsett, M; Doody, D; Miall, S; Howes, A; English, J; Coombes, RC
      Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    44. Makris, A; Powles, TJ; Allred, DC; Ashley, SE; Trott, PA; Ormerod, MG; Titley, JC; Dowsett, M
      Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study

      BREAST CANCER RESEARCH AND TREATMENT
    45. Detre, S; Salter, J; Barnes, DM; Riddler, S; Hills, M; Johnston, SRD; Gillett, C; A'Hern, R; Dowsett, M
      Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts

      INTERNATIONAL JOURNAL OF CANCER
    46. Johnston, SRD; Boeddinghaus, IM; Riddler, S; Haynes, BP; Hardcastle, IR; Rowlands, M; Grimshaw, R; Jarman, M; Dowsett, M
      Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis

      CANCER RESEARCH
    47. Makris, A; Powles, TJ; Kakolyris, S; Dowsett, M; Ashley, SE; Harris, AL
      Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

      CANCER
    48. Dowsett, M; Tobias, JS; Howell, A; Blackman, GM; Welch, H; King, N; Ponzone, R; von Euler, M; Baum, M
      The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer

      BRITISH JOURNAL OF CANCER
    49. Mainwaring, PN; Dowsett, M
      LHRH superagonists and antagonists in the treatment of breast cancer

      ENDOCRINOLOGY OF BREAST CANCER
    50. GEISLER J; KING N; ANKER G; ORNATI G; DISALLE E; LONNING PE; DOWSETT M
      IN-VIVO INHIBITION OF AROMATIZATION BY EXEMESTANE, A NOVEL IRREVERSIBLE AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS

      Clinical cancer research
    51. JOHNSTON SRD; DOWSETT M; RIDDLER S; JARMAN M
      IDOXIFENE ANTAGONISM OF ESTRADIOL-DEPENDENT MCF-7 BREAST-CANCER XENOGRAFT GROWTH

      European journal of cancer
    52. DOWSETT M; YATES R; WONG YWJ
      ARIMIDEX (ANASTROZOLE) - LACK OF INTERACTIONS WITH TAMOXIFEN, ANTIPYRINE, CIMETIDINE AND WARFARIN

      European journal of cancer
    53. GREGORY RK; ELLIS PA; POWLES TJ; DOWSETT M
      APOPTOTIC INDEX (AL) AND KI67 AS PROGNOSTIC FACTORS IN A TRIAL OF PRIMARY MEDICAL THERAPY (PMT) FOR PRIMARY-CARCINOMA OF THE BREAST

      Annals of oncology
    54. DOWSETT M
      HORMONAL RECEPTORS IN BREAST-CANCER

      Annals of oncology
    55. DOWSETT M; DETRE S; ORMEROD MG; ELLIS PA; MAINWARING PN; TITLEY JC; SMITH IE
      ANALYSIS AND SORTING OF APOPTOTIC CELLS FROM FINE-NEEDLE ASPIRATES OFEXCISED HUMAN PRIMARY BREAST CARCINOMAS

      Cytometry
    56. DOWSETT M
      THEORETICAL CONSIDERATIONS FOR THE IDEAL AROMATASE INHIBITOR

      Breast cancer research and treatment
    57. LONNING PE; GEISLER J; DOWSETT M
      PHARMACOLOGICAL AND CLINICAL PROFILE OF ANASTROZOLE

      Breast cancer research and treatment
    58. BHATNAGAR A; DOWSETT M; SANTEN D; SMITH I; BOEHM R; LONNING P; TEDESCHI M; LASSUS M; MILLER B; TOMINAGA T
      PHARMACOLOGICAL PROFILE OF AN IDEAL AROMATASE INHIBITOR IN THE TREATMENT OF BREAST-CANCER - DISCUSSION OF SESSION 2

      Breast cancer research and treatment
    59. SHENTON KC; DOWSETT M; LU Q; BRODIE A; SASANO H; SACKS NPM; ROWLANDS MG
      COMPARISON OF BIOCHEMICAL AROMATASE-ACTIVITY WITH AROMATASE IMMUNOHISTOCHEMISTRY IN HUMAN BREAST CARCINOMAS

      Breast cancer research and treatment
    60. ELLIS PA; SMITH IE; DETRE S; BURTON SA; SALTER J; AHERN R; WALSH G; JOHNSTON SRD; DOWSETT M
      REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY

      Breast cancer research and treatment
    61. MAKRIS A; POWLES TJ; ALLRED DC; ASHLEY S; ORMEROD MG; TITLEY JC; DOWSETT M
      CHANGES IN HORMONE RECEPTORS AND PROLIFERATION MARKERS IN TAMOXIFEN TREATED BREAST-CANCER PATIENTS AND THE RELATIONSHIP WITH RESPONSE

      Breast cancer research and treatment
    62. POWLES T; EELES R; ASHLEY S; EASTON D; CHANG J; DOWSETT M; TIDY A; VIGGERS J; DAVEY J
      INTERIM ANALYSIS OF THE INCIDENCE OF BREAST-CANCER IN THE ROYAL-MARSDEN-HOSPITAL TAMOXIFEN RANDOMIZED CHEMOPREVENTION TRIAL

      Lancet
    63. DOWSETT M
      IMPROVED PROGNOSIS FOR BIOMARKERS IN BREAST-CANCER

      Lancet
    64. MAINWARING PN; ELLIS PA; DETRE S; SMITH IE; DOWSETT M
      COMPARISON OF IN-SITU METHODS TO ASSESS DNA CLEAVAGE IN APOPTOTIC CELLS IN PATIENTS WITH BREAST-CANCER

      Journal of Clinical Pathology
    65. GREGORY R; ELLIS P; POWLES T; DOWSETT M
      APOPTOTIC INDEX AS A PROGNOSTIC FACTOR IN A TRIAL OF PRIMARY MEDICAL THERAPY FOR CARCINOMA OF THE BREAST

      British Journal of Cancer
    66. ARCHER CD; ASHLEY S; DOWSETT M; SMITH IE
      BIOMARKERS FOR THE PREDICTION OF COMPLETE CLINICAL-RESPONSE TO PRIMARY CHEMOTHERAPY IN EARLY BREAST-CANCER

      British Journal of Cancer
    67. DOWSETT M
      AROMATASE INHIBITORS - CURRENT STATUS AND FUTURE APPLICATIONS

      Endocrine-related cancer
    68. NEWBY JC; JOHNSTON SRD; SMITH IE; DOWSETT M
      EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 DURING THEDEVELOPMENT OF TAMOXIFEN RESISTANCE IN HUMAN BREAST-CANCER

      Clinical cancer research
    69. MAKRIS A; POWLES TJ; DOWSETT M; OSBORNE CK; TROTT PA; FERNANDO IN; ASHLEY SE; ORMEROD MG; TITLEY JC; GREGORY RK; ALLRED DC
      PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOENDOCRINE THERAPY IN PRIMARY BREAST CARCINOMAS

      Clinical cancer research
    70. ANDERSEN TI; WOOSTER R; LAAKE K; COLLINS N; WARREN W; SKREDE M; EELES R; TVEIT KM; JOHNSTON SRD; DOWSETT M; OLSEN AO; MOLLER P; STRATTON MR; BORRESENDALE AL
      SCREENING FOR ESR MUTATIONS IN BREAST AND OVARIAN-CANCER PATIENTS

      Human mutation
    71. CHAN CMW; DOWSETT M
      A NOVEL ESTROGEN-RECEPTOR VARIANT MESSENGER-RNA LACKING EXON-4 TO EXON-6 IN BREAST-CARCINOMA

      Journal of steroid biochemistry and molecular biology
    72. DOWSETT M
      FUTURE USES FOR AROMATASE INHIBITORS IN BREAST-CANCER

      Journal of steroid biochemistry and molecular biology
    73. BARRIE SE; HAYNES BP; POTTER GA; CHAN FCY; GODDARD PM; DOWSETT M; JARMAN M
      BIOCHEMISTRY AND PHARMACOKINETICS OF POTENT NONSTEROIDAL CYTOCHROME P450(17-ALPHA) INHIBITORS

      Journal of steroid biochemistry and molecular biology
    74. HOWELL A; DOWSETT M
      RECENT ADVANCES IN ENDOCRINE THERAPY OF BREAST-CANCER

      BMJ. British medical journal
    75. DOWSETT M; DAFFADA A; CHAN CMW; JOHNSTON SRD
      ESTROGEN-RECEPTOR MUTANTS AND VARIANTS IN BREAST-CANCER

      European journal of cancer
    76. TOBIAS JS; BAUM M; BLACKMAN GM; DOWSETT M; KING N; HOWELL A; WELCH H
      A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP TRIAL TO EVALUATE THE EFFECT OF THE AROMATASE INHIBITOR ANASTROZOLE ON THE PHARMACOKINETICS OF TAMOXIFEN (TAM) IN POSTMENOPAUSAL BREAST-CANCER PATIENTS

      European journal of cancer
    77. DOWSETT M
      AROMATASE INHIBITORS COME OF AGE

      Annals of oncology
    78. DETRE S; ORMEROD MG; TITLEY JC; DOWSETT M
      AN UNUSUAL ARTIFACT IN THE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE ASSAY FOR APOPTOTIC CELLS

      Cytometry
    79. MAKRIS A; ALLRED DC; POWLES TJ; DOWSETT M; FERNANDO IN; TROTT PA; ASHLEY SE; ORMEROD MG; TITLEY JC; OSBORNE CK
      CYTOLOGICAL EVALUATION OF BIOLOGICAL PROGNOSTIC MARKERS FROM PRIMARY BREAST CARCINOMAS

      Breast cancer research and treatment
    80. ELLIS PA; SMITH IE; MCCARTHY K; DETRE S; SALTER J; DOWSETT M
      PREOPERATIVE CHEMOTHERAPY INDUCES APOPTOSIS IN EARLY BREAST-CANCER

      Lancet
    81. DOWSETT M; LONNING PE
      ANASTROZOLE - A NEW-GENERATION IN AROMATASE INHIBITION - CLINICAL-PHARMACOLOGY

      Oncology
    82. KLEEBERG UR; DOWSETT M; CARRION RP; DODWELL DJ; VOROBIOF DA; APARICIO LA; ROBERTSON JFR
      A RANDOMIZED COMPARISON OF ESTROGEN SUPPRESSION WITH ANASTROZOLE AND FORMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

      Oncology
    83. ZHU X; DAFFADA AAI; CHAN CMW; DOWSETT M
      IDENTIFICATION OF AN EXON-3 DELETION SPLICE VARIANT ANDROGEN RECEPTORMESSENGER-RNA IN HUMAN BREAST-CANCER

      International journal of cancer
    84. ELLIS PA; SACCANIJOTTI G; CLARKE R; JOHNSTON SRD; ANDERSON E; HOWELL A; AHERN R; SALTER J; DETRE S; NICHOLSON R; ROBERTSON J; SMITH IE; DOWSETT M
      INDUCTION OF APOPTOSIS BY TAMOXIFEN AND ICI-182780 IN PRIMARY BREAST-CANCER

      International journal of cancer
    85. JOHNSTON SRD; LU B; DOWSETT M; LIANG X; KAUFMANN M; SCOTT GK; OSBORNE CK; BENZ CC
      COMPARISON OF ESTROGEN-RECEPTOR DNA-BINDING IN UNTREATED AND ACQUIREDANTIESTROGEN-RESISTANT HUMAN BREAST-TUMORS

      Cancer research
    86. ELLIS PA; LONNING PE; BORRESENDALE A; AAS T; GEISLER S; AKSLEN LA; SALTER I; SMITH IE; DOWSETT M
      ABSENCE OF P21 EXPRESSION IS ASSOCIATED WITH ABNORMAL P53 IN HUMAN BREAST CARCINOMAS

      British Journal of Cancer
    87. THOMAS HV; KEY TJ; ALLEN DS; MOORE JW; DOWSETT M; FENTIMAN IS; WANG DY
      A PROSPECTIVE-STUDY OF ENDOGENOUS SERUM HORMONE CONCENTRATIONS AND BREAST-CANCER RISK IN POSTMENOPAUSAL WOMEN ON THE ISLAND OF GUERNSEY

      British Journal of Cancer
    88. THOMAS HV; KEY TJ; ALLEN DS; MOORE JW; DOWSETT M; FENTIMAN IS; WANG DY
      A PROSPECTIVE-STUDY OF ENDOGENOUS SERUM HORMONE CONCENTRATIONS AND BREAST-CANCER RISK IN PREMENOPAUSAL WOMEN ON THE ISLAND OF GUERNSEY

      British Journal of Cancer
    89. JOHNSTON SRD; RIDDLER S; HAYNES BP; HERN RA; SMITH IE; JARMAN M; DOWSETT M
      THE NOVEL ANTIESTROGEN IDOXIFENE INHIBITS THE GROWTH OF HUMAN MCF-7 BREAST-CANCER XENOGRAFTS AND REDUCES THE FREQUENCY OF ACQUIRED ANTIESTROGEN RESISTANCE

      British Journal of Cancer
    90. THOMAS H; KEY T; ALLEN D; MOORE J; DOWSETT M; FENTIMAN I; WANG D
      A PROSPECTIVE-STUDY OF ENDOGENOUS SERUM HORMONE CONCENTRATIONS AND BREAST-CANCER RISK IN POSTMENOPAUSAL WOMEN

      American journal of epidemiology
    91. THOMAS HV; KEY TJ; ALLEN DS; MOORE JW; DOWSETT M; FENTIMAN IS; WANG DY
      REVERSAL OF RELATION BETWEEN BODY-MASS AND ENDOGENOUS ESTROGEN CONCENTRATIONS WITH MENOPAUSAL STATUS

      Journal of the National Cancer Institute
    92. DOWSETT M; HILL C
      3-DIMENSIONAL CHEMICAL CHARACTERIZATION OF ELECTRONIC MATERIALS - PREFACE

      Philosophical transactions-Royal Society of London. Physical sciences and engineering
    93. SAUNDERS C; DOWSETT M; BAUM M
      EFFECT OF PRE-MEDICATION DRUGS ON SERUM HORMONE LEVELS IN WOMEN UNDERGOING BREAST SURGERY

      Breast
    94. ANDERSON E; NICHOLSON R; DOWSETT M; HOWELL A
      MODELS OF NEW ANTIESTROGEN ACTION IN-VIVO - PRIMARY TUMORS

      Breast
    95. DOWSETT M
      BIOLOGICAL BACKGROUND TO AROMATASE INHIBITION

      Breast
    96. DOWSETT M; LEE K; MACAULAY VM; DETRE S; ROWLANDS M; GRIMSHAW R
      THE CONTROL AND BIOLOGICAL IMPORTANCE OF INTRATUMORAL AROMATASE IN BREAST-CANCER

      Journal of steroid biochemistry and molecular biology
    97. DOWSETT M
      ENDOCRINE TREATMENT OF ADVANCED BREAST-CANCER

      Acta oncologica
    98. DOWSETT M
      ENDOCRINE RESISTANCE IN ADVANCED BREAST-CANCER

      Acta oncologica
    99. MCCLELLAND RA; MANNING DL; GEE JMW; ANDERSON E; CLARKE R; HOWELL A; DOWSETT M; ROBERTSON JE; BLAMEY RW; WAKELING AE; NICHOLSON RI
      EFFECTS OF SHORT-TERM ANTIESTROGEN TREATMENT OF PRIMARY BREAST-CANCERON ESTROGEN-RECEPTOR MESSENGER-RNA AND PROTEIN EXPRESSION AND ON ESTROGEN-REGULATED GENES

      Breast cancer research and treatment
    100. JEYARAJAH AR; GALLAGHER CJ; BLAKE PR; ORAM DH; DOWSETT M; FISHER C; OLIVER RTD
      LONG-TERM FOLLOW-UP OF GONADOTROPIN-RELEASING-HORMONE ANALOG TREATMENT FOR RECURRENT ENDOMETRIAL CANCER

      Gynecologic oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 03:42:02